MIRM and INCY Related Headlines
Go Back- Mirum and Incyte to present zilurgisertib study results at ENDO 2026
- Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026
- JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

